Research ArticleArticle
Open Access
Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
BOULOS HARAOUI, MARIA BOKAREWA, IAN KALLMEYER and VIVIAN P. BYKERK
The Journal of Rheumatology December 2011, 38 (12) 2548-2556; DOI: https://doi.org/10.3899/jrheum.110444
BOULOS HARAOUI
MARIA BOKAREWA
IAN KALLMEYER
REFERENCES
- 1.↵
- Ruddy S,
- Harris ED,
- Sledge CB
- Firestein GS
- 2.↵
- 3.↵
- 4.↵
- Burmester GR,
- Monteagudo I,
- Saez I,
- Malaise MG,
- Canas da Silva J,
- Webber DG,
- et al.
- 5.↵
- Emery P,
- Keystone E,
- Tony H-P,
- Cantagrel A,
- van Vollenhoven R,
- Sanchez A,
- et al.
- 6.↵
- 7.↵
- Smolen J,
- Kay J,
- Doyle MK,
- Landewé R,
- Matteson EL,
- Wollenhaupt J,
- et al.
- 8.↵Rituxan (rituximab) product monograph. Hoffmann-La Roche Canada Ltd. June 2010.
- 9.↵
- 10.↵
- 11.↵
- Rubbert-Roth A,
- Tak PP,
- Zerbini C,
- Tremblay J-L,
- Carreno L,
- Armstrong G,
- et al;
- on behalf of the MIRROR Trial Investigators
- 12.↵
- Emery P,
- Deodhar A,
- Rigby WF,
- Isaacs JD,
- Combe B,
- Racewicz AJ,
- et al.
- 13.↵
- Tak PP,
- Rigby WF,
- Rubbert-Roth A,
- Peterfy CG,
- van Vollenhoven RF,
- Stohl W,
- et al;
- for the IMAGE Investigators
- 14.↵
- 15.↵
- van Vollenhoven RF,
- Emery P,
- Bingham CO III.,
- Keystone EC,
- Fleishmann RM,
- Furst DE,
- et al.
- 16.↵
- 17.↵
- Keystone EC,
- Fleischmann RM,
- Emery P,
- Dougados M,
- Williams S,
- Linnik MD,
- et al.
- 18.↵
- Guidance for industry clinical safety data management
- 19.↵
- Cohen S,
- Keystone E,
- Genovese MC,
- Emery P,
- Peterfy C,
- Tak PP,
- et al.
- 20.↵
- Isaacs JD,
- Olech E,
- Tak PP,
- Deodhar A,
- Keystone E,
- Emery P,
- et al.
- 21.↵
- Mariette X,
- Kivitz A,
- Isaacs J,
- Stohl W,
- Tak PP,
- Jones R,
- et al.
In this issue
The Journal of Rheumatology
Vol. 38, Issue 12
1 Dec 2011
Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
BOULOS HARAOUI, MARIA BOKAREWA, IAN KALLMEYER, VIVIAN P. BYKERK
The Journal of Rheumatology Dec 2011, 38 (12) 2548-2556; DOI: 10.3899/jrheum.110444
Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
BOULOS HARAOUI, MARIA BOKAREWA, IAN KALLMEYER, VIVIAN P. BYKERK
The Journal of Rheumatology Dec 2011, 38 (12) 2548-2556; DOI: 10.3899/jrheum.110444